Discontinuation of tyrosine kinase inhibitors based on bcr-abl1 monitoring by digital droplet pcr in pediatric chronic myeloid leukemia

HIGHLIGHTS

• who: Nack-Gyun Chung and Myungshin Kim from the University of Tu00fcbingen, Germany have published the Article: Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia, in the Journal: (JOURNAL)
• what: The authors aimed to demonstrate the feasibility of ddPCR to determine TKI discontinuation and to monitor steady DMRs for pediatric CML patients by comparing the results with those of RT-qPCR.

SUMMARY

The authors quantified BCR-ABL1 using RT-qPCR and ddPCR in pediatric CML patients treated with TKI. The . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.